SARS-CoV-2 Omicron Infection Linked to Increased Risk of Reinfection
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 24, 2023 -- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) omicron infection is associated with increased risk of reinfection among residents of long-term care and retirement homes, according to a study published online Aug. 21 in eClinicalMedicine.
Jessica A. Breznik, Ph.D., from McMaster University in Hamilton, Canada, and colleagues examined the incidence of SARS-CoV-2 Omicron infection in 750 vaccinated residents of long-term care and retirement homes in an observational study within July to September 2022. In a subset of 318 residents, serum anti-spike and anti-receptor binding domain (RBD) SARS-CoV-2 immunoglobulin (Ig)G and IgA antibodies, microneutralization titers, and spike-specific T cell memory responses were examined within the preceding three months.
The researchers found that during the observation period, 17.7 percent of the 750 participants had a polymerase chain reaction-confirmed Omicron infection. There was an association for increased infection risk with prior Omicron infection (at nine to 29 days: 47.67, which was not attributed to days since fourth vaccination or residence outbreaks). After their initial Omicron infection, reinfected participants had lower serum neutralizing antibodies to ancestral and Omicron BA.1 SARS-CoV-2, and lower anti-RBD IgG and IgA antibodies.
"Overall, our observations caution that immunological features of hybrid immunity are not the same in all older adults, and hybrid immunity should not be considered a panacea against future SARS-CoV-2 infection, whether from cross-subvariant Omicron infections, or future variants of concern," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
AI Can Identify Guardian Authorship of Messages in Teen Patient Portal
FRIDAY, June 28, 2024 -- Large language model (LLM)-based classifiers can accurately detect guardian authorship of messages sent from an adolescent patient portal, according to a...
Survival Improves With Open Hysterectomy for Cervical Cancer
FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical...
Precision-Guided Treatment Improves Outcomes for High-Risk Pediatric Cancer
FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June 6 in Nature Medicine. Loretta...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.